Experimental Pill Nearly Doubles Survival in Pancreatic Cancer
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
Managing debt can be challenging. Explore additional income ideas for debt repayment and regain your financial stability.
12,513 articlesA late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
As inflation concerns linger, institutional moves into commodity-focused ETFs attract attention. This article breaks ...
XRP spot ETFs posted solid inflows in May, while Bitcoin ETFs endured a multiday outflow stretch, signaling a shift i...
Ethereum-focused ETFs faced a heavy outflow spell, totaling $708 million over 14 sessions, while XRP and Solana poste...
apollo chief economist says AI is not killing jobs; the Apollo Global Management economist argues the tech boom is li...
Anthropic has confidentially filed its S-1, signaling a high-stakes move in the AI IPO race as investors weigh growth...
Hims & Hers has shown volatility, but can the stock be undervalued? This guide breaks down the business, key risks, a...
A top AI analyst argues the AI revolution is still in its early stages, with ASML’s hefty backlog and robust Q1 2026 ...
A 60-year-old who converted $400,000 to a Roth IRA in 2025 plans a $50,000 withdrawal in 2026, only to confront two s...
Realtor.com rolls out RealAssist AI in beta, letting buyers chat their way to homes, explore affordability, and conne...
Intel overcame a tough 12 months to deliver a striking rebound. Analysts say the AI-led strategy and foundry expansio...
When a major tech supplier delivers a standout quarter, investors take notice. This article explains why hewlett pack...